Elly Ryu - 22 Apr 2021 Form 3 Insider Report for Sesen Bio, Inc. (CARM)

Role
Principal Accounting Officer
Signature
/s/ Mark R. Sullivan, as attorney-in-fact
Issuer symbol
CARM
Transactions as of
22 Apr 2021
Net transactions value
$0
Form type
3
Filing time
10 May 2021, 20:43:25 UTC
Next filing
04 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CARM Common Stock 11,696 22 Apr 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CARM Employee Stock Option (Right to Buy) 22 Apr 2021 Common Stock 80,000 $3.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on 03/16/2021. 25% of the shares subject to such option shall vest on the first anniversary of the date of grant of the option and an additional 6.25% of the shares underlying the option shall vest at the end of each successive three-month period thereafter until the fourth anniversary of the date of grant of the option.

Remarks:

Exhibit List: Exhibit 24: Power of Attorney